Literature DB >> 20231066

Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters.

Gerben R Borst1, Masayori Ishikawa, Jasper Nijkamp, Michael Hauptmann, Hiroki Shirato, Gerard Bengua, Rikiya Onimaru, A de Josien Bois, Joos V Lebesque, Jan-Jakob Sonke.   

Abstract

PURPOSE: To evaluate the linear quadratic (LQ) model for hypofractionated radiotherapy within the context of predicting radiation pneumonitis (RP) and to investigate the effect if a linear (L) model in the high region (LQL model) is used. METHODS AND MATERIALS: The radiation doses used for 128 patients treated with hypofractionated radiotherapy were converted to the equivalent doses given in fractions of 2 Gy for a range of alpha/beta ratios (1 Gy to infinity) according to the LQ(L) model. For the LQL model, different cut-off values between the LQ model and the linear component were used. The Lyman model parameters were fitted to the events of RP grade 2 or higher to derive the normal tissue complication probability (NTCP). The lung dose was calculated as the mean lung dose and the percentage of lung volume (V) receiving doses higher than a threshold dose of xGy (V(x)).
RESULTS: The best NTCP fit was found if the mean lung dose, or V(x), was calculated with an alpha/beta ratio of 3 Gy. The NTCP fit of other alpha/beta ratios and the LQL model were worse but within the 95% confidence interval of the NTCP fit of the LQ model with an alpha/beta ratio of 3 Gy. The V(50) NTCP fit was better than the NTCP fit of lower threshold doses.
CONCLUSIONS: For high fraction doses, the LQ model with an alpha/beta ratio of 3 Gy was the best method for converting the physical lung dose to predict RP. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20231066     DOI: 10.1016/j.ijrobp.2009.10.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  24 in total

1.  Dose-Volume Predictors of Radiation Pneumonitis After Lung Stereotactic Body Radiation Therapy (SBRT): Implications for Practice and Trial Design.

Authors:  Vitali Moiseenko; Jimm Grimm; Ellen Yorke; Andrew Jackson; Anthony Yip; Minh-Phuong Huynh-Le; Anand Mahadevan; Kenneth Forster; Michael T Milano; Jona A Hattangadi-Gluth
Journal:  Cureus       Date:  2020-10-05

Review 2.  Preclinical animal research on therapy dosimetry with dual isotopes.

Authors:  Mark W Konijnenberg; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-01       Impact factor: 9.236

3.  The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment.

Authors:  Irma W E M van Dijk; Rob M van Os; Jeroen B van de Kamer; Nicolaas A P Franken; Helena J H van der Pal; Caro C E Koning; Huib N Caron; Cécile M Ronckers; Leontien C M Kremer
Journal:  J Cancer Surviv       Date:  2014-06-14       Impact factor: 4.442

4.  Non-coplanar VMAT combined with non-uniform dose prescription markedly reduces lung dose in breath-hold lung SBRT.

Authors:  Jens Fleckenstein; Judit Boda-Heggemann; Kerstin Siebenlist; Tanya Gudzheva; Natallia Prakofyeva; Frank Lohr; Frederik Wenz; Anna Simeonova-Chergou
Journal:  Strahlenther Onkol       Date:  2018-05-25       Impact factor: 3.621

5.  Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.

Authors:  Gurleen Dhami; Jing Zeng; Hubert J Vesselle; Paul E Kinahan; Robert S Miyaoka; Shilpen A Patel; Ramesh Rengan; Stephen R Bowen
Journal:  Strahlenther Onkol       Date:  2017-03-02       Impact factor: 3.621

6.  Correlations Between Serum IL-6 Levels and Radiation Pneumonitis in Lung Cancer Patients: A Meta-Analysis.

Authors:  Zhan-Zhao Fu; Yong Peng; Li-Yan Cao; Yan-Sheng Chen; Kun Li; Bao-Hong Fu
Journal:  J Clin Lab Anal       Date:  2014-12-26       Impact factor: 2.352

7.  Prediction of radiation pneumonitis with machine learning using 4D-CT based dose-function features.

Authors:  Yoshiyuki Katsuta; Noriyuki Kadoya; Shina Mouri; Shohei Tanaka; Takayuki Kanai; Kazuya Takeda; Takaya Yamamoto; Kengo Ito; Tomohiro Kajikawa; Yujiro Nakajima; Keiichi Jingu
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

8.  Local and Global Function Model of the Liver.

Authors:  Hesheng Wang; Mary Feng; Andrew Jackson; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-10-09       Impact factor: 7.038

9.  Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.

Authors:  Howard J Lee; Jing Zeng; Hubert J Vesselle; Shilpen A Patel; Ramesh Rengan; Stephen R Bowen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

10.  Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy.

Authors:  Hannah Mary T Thomas; Jing Zeng; Howard J Lee; Balu Krishna Sasidharan; Paul E Kinahan; Robert S Miyaoka; Hubert J Vesselle; Ramesh Rengan; Stephen R Bowen
Journal:  Br J Radiol       Date:  2019-08-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.